Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of March 29, 2020
New CAR T cells with synthetic ankyrin repeats
From the Riddell Laboratory, Clinical Research Division
Targeting metastatic breast cancer with CAR T-cell immunotherapy
$4M 'Breakthrough' award funds collaborative research aimed at destroying dormant disseminated tumor cells
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
The New Yorker spotlights Fred Hutch’s pioneering cancer research
‘The Promise and Price of Cellular Therapies’ by Siddhartha Mukherjee traces journey from bone marrow transplantation to immunotherapy
Logic-gated CAR-T cells safely target distant tumor cells
From the Riddell Laboratory, Clinical Research Division
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
“Exciting” but early results in trial of immunotherapy for myeloma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease
Colette Chaney named ‘2018 Nurse of the Year for Research Advancement’
March of Dimes Washington honors the longtime immunotherapy clinical research nurse
Forbes '30 Under 30' lists Hutch immunotherapy researcher Alex Salter
Grad student on short list of young health care influencers
Stronger and faster is not always better
From the Riddell, Paulovich Labs, Clinical Research Division and Gottardo Lab, Vaccine and Infectious Disease Division.
Dr. Marie Bleakley named Gerdin Family Endowed Chair for Leukemia Research
Pediatric cancer physician-scientist feted at rooftop reception
First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy
A Science Signaling paper reports how two common CAR designs impact T-cell efficacy against cancer in the laboratory
Want to make better T-cell therapies? First, figure out how they work.
New study maps out activities, effects of widely used components in cellular immunotherapies
His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?
How one man’s T cells are guiding the development of next-gen immunotherapies
Tinkering with T cells
How researchers are tweaking engineered immune cells’ cancer-targeting receptors — and why it matters
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Promising results in trial of engineered T cells in high-risk leukemia
High response rates to experimental immunotherapy in patients with treatment-resistant chronic lymphocytic leukemia
Dr. Hootie Warren takes helm of Fred Hutch Global Oncology
Immunotherapy researcher, cancer doctor set to lead a new worldwide revolution in care
The human version makes it better
from the Riddell lab (Clinical Research Division)